MET and chronic myelogenous leukemia, BCR-ABL1 positive: HIF-1α functions as a critical transcriptional regulator in chronic myeloid leukemia (CML), driving leukemic cell survival and proliferation through upregulation of BCR-ABL and Met oncogenic pathways (145).